Yossi Maimon
2019 - Ayala Pharmaceuticals
In 2019, Yossi Maimon earned a total compensation of $727.7K as Chief Financial Officer at Ayala Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $74,571 |
|---|---|
| Option Awards | $357,776 |
| Salary | $217,103 |
| Other | $78,278 |
| Total | $727,728 |
Maimon received $357.8K in option awards, accounting for 49% of the total pay in 2019.
Maimon also received $74.6K in non-equity incentive plan, $217.1K in salary and $78.3K in other compensation.
Rankings
In 2019, Yossi Maimon's compensation ranked 10,565th out of 13,971 executives tracked by ExecPay. In other words, Maimon earned more than 24.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,565 out of 13,971 | 24th |
Division Manufacturing | 4,271 out of 5,701 | 25th |
Major group Chemicals And Allied Products | 1,656 out of 2,200 | 25th |
Industry group Drugs | 1,417 out of 1,886 | 25th |
Industry Biological Products, Except Diagnostic Substances | 317 out of 389 | 19th |
Source: SEC filing on April 27, 2021.
Maimon's colleagues
We found two more compensation records of executives who worked with Yossi Maimon at Ayala Pharmaceuticals in 2019.